-
Post date
January 14, 2022
-
Posted by
Kieran Robertson
-
Posted in
clinical trial, clinical trials psilocybin 2021, Mushrooms, NBIO-01, NUMI.T, Numinus Health, numinus stock, Numinus Wellness Inc., Numinus Wellness Inc. (NUMI.T), Patent, Patent Application, patent pending, process technology, psilocybin, psychedelic-assisted psychotherapies, Psychedelics